From GlobeNewswire: 2024-11-22 06:00:00

Scilex Holding Company received a notice from Nasdaq stating it was not in compliance with listing requirements due to a late filing. The company has until January 20, 2025, to submit a plan to regain compliance. If accepted, they may have until May 19, 2025, to comply. Scilex intends to file the overdue report promptly or submit a plan to Nasdaq outlining steps to do so. The company focuses on non-opioid pain management products and has commercial products like ZTlido®, ELYXYB®, and Gloperba®, with three product candidates in development. Scilex is headquartered in Palo Alto, California.



Read more at GlobeNewswire: Scilex Holding Company Announces Receipt of Notice from